ES2046217T3 - Lanosteroles 14,15-sustituidos y su uso como agentes hipocolesterolemicos. - Google Patents

Lanosteroles 14,15-sustituidos y su uso como agentes hipocolesterolemicos.

Info

Publication number
ES2046217T3
ES2046217T3 ES198888101139T ES88101139T ES2046217T3 ES 2046217 T3 ES2046217 T3 ES 2046217T3 ES 198888101139 T ES198888101139 T ES 198888101139T ES 88101139 T ES88101139 T ES 88101139T ES 2046217 T3 ES2046217 T3 ES 2046217T3
Authority
ES
Spain
Prior art keywords
lanosterols
substituted
hypocholesterolemic agents
activity
desmetilase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198888101139T
Other languages
English (en)
Inventor
James Leroy Gaylor
Robert Paul Johnson
Soo Sung Ko
Ronald Louis Magolda
Simon Hendrik Stam
James Michael Trzaskos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Pharma Co
Original Assignee
DuPont Merck Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DuPont Merck Pharmaceutical Co filed Critical DuPont Merck Pharmaceutical Co
Application granted granted Critical
Publication of ES2046217T3 publication Critical patent/ES2046217T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0016—Oximes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring

Abstract

LA INVENCION SE REFIERE A LANOSTEROLES SUSTITUIDOS EN LAS POSICIONES 14 Y/O 15 QUE TIENEN ACTIVIDAD ENHIBIDORA DE LANOSTA-8,24-DIAN-3BETA-OL-14ALFA-METIL-DESMETILASA, ACTIVIDAD SUPRESORA DE 3-HIDROXI-3-METILGLUTARIL COENZIMA A-REDUCTASA (HMGR), DISMINUYEN LA SINTESIS DE COLESTEROL Y REDUCEN LOS NIVELES DE COLESTEROL DEL SUERO.
ES198888101139T 1987-01-30 1988-01-27 Lanosteroles 14,15-sustituidos y su uso como agentes hipocolesterolemicos. Expired - Lifetime ES2046217T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US881287A 1987-01-30 1987-01-30
US9063487A 1987-08-28 1987-08-28

Publications (1)

Publication Number Publication Date
ES2046217T3 true ES2046217T3 (es) 1994-02-01

Family

ID=26678653

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198888101139T Expired - Lifetime ES2046217T3 (es) 1987-01-30 1988-01-27 Lanosteroles 14,15-sustituidos y su uso como agentes hipocolesterolemicos.

Country Status (17)

Country Link
EP (1) EP0276823B1 (es)
KR (1) KR880009037A (es)
AU (1) AU611882B2 (es)
CA (1) CA1328449C (es)
DE (1) DE3874763T2 (es)
DK (1) DK47788A (es)
ES (1) ES2046217T3 (es)
FI (1) FI880417A (es)
GR (1) GR3006422T3 (es)
HU (1) HUT49145A (es)
IE (1) IE59999B1 (es)
IL (1) IL85254A0 (es)
MY (1) MY102582A (es)
NO (1) NO880409L (es)
NZ (1) NZ223344A (es)
PT (1) PT86665B (es)
ZA (1) ZA88655B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023250A (en) * 1989-08-24 1991-06-11 Smithkline Beecham Corporation Steroidal 14α-carboxy-alkyl derivatives as regulators of HMG-COA reductase
US5219879A (en) * 1990-03-05 1993-06-15 Du Pont Merck Pharmaceutical Company Heterocyclic steroid compounds
US6093389A (en) * 1997-12-01 2000-07-25 American Cyanamid Company Methods and compositions for attracting and controlling termites
IL139241A0 (en) * 1998-05-13 2001-11-25 Novo Nordisk As Meiosis regulating compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4202891A (en) * 1977-05-16 1980-05-13 Kandutsch Andrew A 15-Oxygenated sterol compounds and the use of such compounds to inhibit the biosynthesis of sterols

Also Published As

Publication number Publication date
DK47788A (da) 1988-07-31
EP0276823A2 (en) 1988-08-03
ZA88655B (en) 1989-09-27
IE59999B1 (en) 1994-05-18
CA1328449C (en) 1994-04-12
NZ223344A (en) 1990-12-21
IE880241L (en) 1988-07-30
DE3874763D1 (de) 1992-10-29
AU611882B2 (en) 1991-06-27
DE3874763T2 (de) 1993-04-01
NO880409L (no) 1988-08-01
MY102582A (en) 1992-07-31
FI880417A0 (fi) 1988-01-29
DK47788D0 (da) 1988-01-29
EP0276823A3 (en) 1989-01-25
FI880417A (fi) 1988-07-31
KR880009037A (ko) 1988-09-13
EP0276823B1 (en) 1992-09-23
HUT49145A (en) 1989-08-28
AU1117188A (en) 1988-08-04
PT86665A (pt) 1988-02-01
IL85254A0 (en) 1988-07-31
NO880409D0 (no) 1988-01-29
PT86665B (pt) 1992-02-28
GR3006422T3 (es) 1993-06-21

Similar Documents

Publication Publication Date Title
IT1111481B (it) Protesi di tendine o legamento
FI883653A0 (fi) Mikrobeja tappava mikroemulsio
DK0493480T3 (da) Dehydrodidemnin B
DE3880047D1 (de) Zusammensetzung eines zusatzes.
DE69008423D1 (de) Dynamische Fixierung von Schweinsaortaklappen.
ES2104392T3 (es) Pañal desechable.
DE3584580D1 (de) Formen und formulierungen des nedocromil-natriumsalzes.
IT1104141B (it) Corredo per la determinazione della presenza e quantita'di lipoproteine
IT7826450A0 (it) Disposizione circuitale per la compressione o l'espansione facoltativa di dinamica.
ES2046217T3 (es) Lanosteroles 14,15-sustituidos y su uso como agentes hipocolesterolemicos.
PT734380E (pt) 4-benzoilisoxazois e sua utilizacao como herbicidas
AR226718A1 (es) Instrumento abrochador quirurgico
MX9304070A (es) Piperidilamidas, piperidilsulfonamidas y piperidilsulfoxamidas novedosas como inhibidores de la biosintesis del colesterol.
DE3888727T2 (de) Verwendung von Äthylamin-Derivaten als antihypertensive Wirkstoffe.
ES2056876T3 (es) Compuestos piperidinilicos 1,4-disustituidos.
ES2062302T3 (es) Determinadas glioxil-ciclohexenodionas.
CU21802A3 (es) Protesis de valvula cardiaca
ES2196802T3 (es) Lactatos de citronelilo y/o de dihidrocitronelilo, su preparacion y su utilizacion.
KR900003361U (ko) 냉장고의 탈취장치
KR900003367U (ko) 냉장고의 탈취장치
FR2429207A1 (fr) (1-alkyl-5-nitro-2-imidazolyl)-vinyl-glyoxal-diacetals, lyl)-vinyl-glyoxal-ciacetals, leur obtention et leur utilisation
DE3990085T1 (de) Ophthalmologisches instrument
IT1079954B (it) Procedimento per la profumazione di carta igienica e simili
IT8420149A0 (it) Attivita' antidislipemica. derivati della pantetina ad
SU1489139A1 (ru) 3-Изобутил-1-(4-тиоцианатофенил)-5-фенил-Δ-пиразолин, проявляющий противовоспалительную активность

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 276823

Country of ref document: ES